UBS Group’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.66K Buy
3,659
+3,615
+8,216% +$3.4K ﹤0.01% 9224
2025
Q4
$43 Sell
44
-4
-8% -$5 ﹤0.01% 10289
2025
Q3
$73 Sell
48
-22,537
-100% -$40.1K ﹤0.01% 9974
2025
Q2
$21.6K Sell
22,585
-24,955
-52% -$30.2K ﹤0.01% 8377
2025
Q1
$59.4K Buy
47,540
+45,527
+2,262% +$173K ﹤0.01% 7447
2024
Q4
$17.8K Buy
2,013
+1,901
+1,697% +$21K ﹤0.01% 7951
2024
Q3
$1.31K Sell
112
-3,760
-97% -$62.2K ﹤0.01% 8666
2024
Q2
$91.6K Buy
3,872
+3,870
+193,500% +$73.6K ﹤0.01% 6235
2024
Q1
$80 Sell
2
-18
-90% -$1.14K ﹤0.01% 8869
2023
Q4
$1.35K Buy
20
+11
+122% +$873 ﹤0.01% 8328
2023
Q3
$891 Sell
9
-2
-18% -$388 ﹤0.01% 8235
2023
Q2
$3.55K Buy
11
+6
+120% +$1.51K ﹤0.01% 7622
2023
Q1
$1.31K Buy
5
+2
+67% +$820 ﹤0.01% 8766
2022
Q4
$862 Buy
3
+2
+200% +$683 ﹤0.01% 10051
2022
Q3
$0 Buy
+1
New +$463 ﹤0.01% 10689
2022
Q2
Sell
-11
Closed -$8K 10671
2022
Q1
$8K Sell
11
-94
-90% -$77.2K ﹤0.01% 8678
2021
Q4
$131K Buy
105
+100
+2,000% +$161K ﹤0.01% 6048
2021
Q3
$9K Sell
5
-20
-80% -$43K ﹤0.01% 8099
2021
Q2
$63K Buy
25
+10
+67% +$24.5K ﹤0.01% 6228
2021
Q1
$37K Sell
15
-3
-17% -$8.92K ﹤0.01% 6827
2020
Q4
$51K Buy
18
+16
+800% +$38.2K ﹤0.01% 6165
2020
Q3
$5K Sell
2
-27
-93% -$66.5K ﹤0.01% 7311
2020
Q2
$70K Buy
29
+6
+26% +$14K ﹤0.01% 5594
2020
Q1
$47K Sell
23
-35
-60% -$89.7K ﹤0.01% 5880
2019
Q4
$178K Buy
58
+29
+100% +$66.4K ﹤0.01% 5674
2019
Q3
$71K Buy
29
+21
+263% +$57.5K ﹤0.01% 5976
2019
Q2
$23K Buy
8
+2
+33% +$5.71K ﹤0.01% 6518
2019
Q1
$16K Sell
6
-2
-25% -$5.67K ﹤0.01% 6489
2018
Q4
$17K Sell
8
-6
-43% -$18.2K ﹤0.01% 6909
2018
Q3
$63K Buy
14
+11
+367% +$55K ﹤0.01% 5974
2018
Q2
$17K Buy
3
+1
+50% +$6.32K ﹤0.01% 6810
2018
Q1
$13K Sell
2
-1
-33% -$8.52K ﹤0.01% 6716
2017
Q4
$31K Buy
+3
New +$23.2K ﹤0.01% 6200

Other funds holding MBIO